treatment-related changes

You have access
Borderline Findings in O-(2-[¹⁸F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
Karl-Josef Langen, Gabriele Stoffels, Christian P. Filss, Martin Kocher, Christoph Lerche, Michael Sabel, Marion Rapp, Hosai Noltemeier, Jan-Michael Werner, Garry Ceccon, Michael M. Wollring, Jurij Rosen, Joachim P. Steinbach, Elke Hattingen, Martin R. Weinzierl, Michael Stoffel, Hans Clusmann, N. Jon Shah, Felix M. Mottaghy, Norbert Galldiks and Philipp Lohmann

Journal of Nuclear Medicine February 1, 2025, 66 (2) 187-193; DOI: https://doi.org/10.2967/jnumed.124.268768
You have access
MRI and ¹⁸F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis
Jurij Rosen, Jan-Michael Werner, Garry S. Ceccon, Elena K. Rosen, Michael M. Wollring, Isabelle Stetter, Philipp Lohmann, Felix M. Mottaghy, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine June 1, 2024, 65 (6) 838-844; DOI: https://doi.org/10.2967/jnumed.123.266687
You have access
Cost Effectiveness of ¹⁸F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine November 1, 2022, 63 (11) 1677-1682; DOI: https://doi.org/10.2967/jnumed.122.263790
You have access
Early Treatment Response Assessment Using ¹⁸F-FET PET Compared with Contrast-Enhanced MRI in Glioma Patients After Adjuvant Temozolomide Chemotherapy
Garry Ceccon, Philipp Lohmann, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Gabriele Stoffels, Jurij Rosen, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Niklas Schäfer, Nadim J. Shah, Gereon R. Fink, Karl-Josef Langen and Norbert Galldiks

Journal of Nuclear Medicine July 1, 2021, 62 (7) 918-925; DOI: https://doi.org/10.2967/jnumed.120.254243
You have access
Treatment Monitoring of Immunotherapy and Targeted Therapy Using ¹⁸F-FET PET in Patients with Melanoma and Lung Cancer Brain Metastases: Initial Experiences
Norbert Galldiks, Diana S.Y. Abdulla, Matthias Scheffler, Fabian Wolpert, Jan-Michael Werner, Martin Hüllner, Gabriele Stoffels, Viola Schweinsberg, Max Schlaak, Nicole Kreuzberg, Jennifer Landsberg, Philipp Lohmann, Garry Ceccon, Christian Baues, Maike Trommer, Eren Celik, Maximilian I. Ruge, Martin Kocher, Simone Marnitz, Gereon R. Fink, Jörg-Christian Tonn, Michael Weller, Karl-Josef Langen, Jürgen Wolf and Cornelia Mauch

Journal of Nuclear Medicine April 1, 2021, 62 (4) 464-470; DOI: https://doi.org/10.2967/jnumed.120.248278
You have access
Flare Phenomenon in O-(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas
Christian P. Filss, Ann K. Schmitz, Gabriele Stoffels, Carina Stegmayr, Philipp Lohmann, Jan Michael Werner, Michael Sabel, Marion Rapp, Roland Goldbrunner, Bernd Neumaier, Felix M. Mottaghy, N. Jon Shah, Gereon R. Fink, Norbert Galldiks and Karl-Josef Langen

Journal of Nuclear Medicine September 1, 2020, 61 (9) 1294-1299; DOI: https://doi.org/10.2967/jnumed.119.238568
You have access
¹⁸F-FET PET Imaging in Differentiating Glioma Progression from Treatment-Related Changes: A Single-Center Experience
Gabriele D. Maurer, Daniel P. Brucker, Gabriele Stoffels, Katharina Filipski, Christian P. Filss, Felix M. Mottaghy, Norbert Galldiks, Joachim P. Steinbach, Elke Hattingen and Karl-Josef Langen

Journal of Nuclear Medicine April 1, 2020, 61 (4) 505-511; DOI: https://doi.org/10.2967/jnumed.119.234757

Main menu

User menu

Search

treatment-related changes